Results were in line with expectations, and guidance was reaffirmed. The stock is likely to trade range-bound near-term. Monitor upcoming quarters for execution on volume recovery and margin trends.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 24 $432.55entry
- T+1 · 7mo ago +3.04%α +2.88% · $445.70
- T+5 · 7mo ago +0.44%α −0.47% · $434.45
- T+20 · 6mo ago −9.25%α −13.27% · $392.56
- T+60 · 4mo ago −14.36%α −18.31% · $370.42
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HCA Healthcare reported Q1 2026 results with revenue of $19.109 billion (4.3% YoY growth) and diluted EPS of $7.15, matching consensus. The company reaffirmed its full-year 2026 guidance and repurchased $1.571 billion in shares. Despite lower respiratory volumes, Medicaid supplemental program recognition offset impacts.
Key Financial Metrics
Key Facts
- Q1 2026 revenue was $19.109 billion, up 4.3% YoY
- Diluted EPS was $7.15, up 10.9% YoY and in line with consensus of $7.15
- Adjusted EBITDA increased 1.9% to $3.802 billion
- Company reaffirmed 2026 full-year guidance: EPS $29.10–$31.50, revenue $76.5–80.0 billion
- Repurchased 3.157 million shares for $1.571 billion during Q1
- Declared quarterly dividend of $0.78 per share
Financial Impact
Revenue increased 4.3% YoY to $19.109 billion; EPS of $7.15 matched consensus
Risk Factors
- Lower-than-expected patient volumes due to reduced respiratory activity
- Dependence on Medicaid supplemental payments for financial performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-174933 |
| Document: hca-20260424.htm | 0001193125-26-174933 |
| Document: 0001193125-26-174933-index-headers.html | 0001193125-26-174933 |
| Document: 0001193125-26-174933-index.html | 0001193125-26-174933 |
| Document: 0001193125-26-174933.txt | 0001193125-26-174933 |
| 8-K Data (Synthetic) | 0001193125-26-174933 |
Track record
19 reports on HCA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $506.04 Now $511.78 +1.13% settles Feb 9
- Nov 6, 202610d ago SC 13D/A Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $494.99 Now $511.78 +3.39% settles Feb 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 2, 202614d ago 8-K Neutral 3/10 Entry $462.86 Now $511.78 +10.57% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $473.19 Now $511.78 +8.16% settles Jan 28
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $463.22 Now $511.78 +10.48% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers